Glycopyrrolate Injection Recalled Due to Manufacturing Quality Deviations
Accord Healthcare is recalling Glycopyrrolate Injection (4 mg/20 mL) from two batches due to CGMP deviations identified during FDA inspection. No illnesses have been reported.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: FDA Class II recall due to manufacturing quality deviations (CGMP) identified during regulatory inspection. No illnesses or injuries have been reported; the hazard relates to potential quality and safety risks from manufacturing defects.
Plain-English summary
Accord Healthcare, Inc. is recalling Glycopyrrolate Injection, USP (4 mg/20 mL, 0.2 mg/mL) across the United States, Puerto Rico, and Canada. The recall affects 322 vials from two batches: R2200431 (expiration 7/31/2023) and R2200439 (expiration 9/30/2023). The product is manufactured by Intas Pharmaceuticals Limited in Ahmedabad, India.
The recall was initiated following an FDA inspection that identified Current Good Manufacturing Practice (CGMP) deviations in the manufacturing process. CGMP standards ensure drugs are manufactured under safe, quality conditions. No illnesses or injuries related to this product have been reported.
If you have received this product, do not use it. Patients and healthcare providers should consult with a pharmacist or healthcare provider about alternative treatments. This product may not meet established quality standards due to the identified manufacturing deviations.
The recalled product
- Product
- GLYCOPYRROLATE (GLYCOPYRROLATE)
- Brand
- GLYCOPYRROLATE
- Manufacturer
- Accord Healthcare, Inc.
- Category
- Drug — Injectable
- Hazard
- manufacturing-defect
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (4)
- Batches: R2200431
- Exp. Date 7/31/2023
- R2200439
- Exp. Date 9/30/2023
UPCs (6)
- 0316729474054
- 0316729472302
- 0316729473316
- 0316729471633
- 316729474054
- 316729474030
Distribution
Distribution scope not specified by the agency.
Related recalls
Same brand · GLYCOPYRROLATE
- ModerateGlycopyrrolate Oral Solution Recalled for Failed Impurities and Degradation Specifications
FDA (Drugs) · 2026-02-04
- ModerateGlycopyrrolate Tablets Recalled Due to Failed Impurities and Degradation Specifications
FDA (Drugs) · 2023-06-28
- ModerateGlycopyrrolate Injection Vials Recalled Due to Labeling Mix-up
FDA (Drugs) · 2023-06-14
- ModerateGlycopyrrolate injection recalled due to manufacturing practice deviations
FDA (Drugs) · 2023-03-08
- HighPrescription Glycopyrrolate Injection Recalled Due to Manufacturing Process Deviations
FDA (Drugs) · 2023-03-08
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27